Cargando…
Transforming growth factor-β pathway activity in glioblastoma
Transforming growth factor (TGF)-β is a central molecule maintaining the malignant phenotype of glioblastoma. Anti-TGF-β strategies are currently being explored in early clinical trials. Yet, there is little contemporary data on the differential expression of TGF-β isoforms at the mRNA and protein l...
Autores principales: | Frei, Karl, Gramatzki, Dorothee, Tritschler, Isabel, Schroeder, Judith Johanna, Espinoza, Larisa, Rushing, Elisabeth Jane, Weller, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467414/ https://www.ncbi.nlm.nih.gov/pubmed/25849941 |
Ejemplares similares
-
A tumor-promoting role for soluble TβRIII in glioblastoma
por: Burghardt, Isabel, et al.
Publicado: (2021) -
Endoglin and TGF-β signaling in glioblastoma
por: Burghardt, Isabel, et al.
Publicado: (2021) -
Venous thromboembolic events in glioblastoma patients: An epidemiological study
por: Eisele, Amanda, et al.
Publicado: (2022) -
Radiotherapy for glioblastoma patients with poor performance status
por: Schröder, Christina, et al.
Publicado: (2021) -
Interleukin-33 in human gliomas: Expression and prognostic significance
por: GRAMATZKI, DOROTHEE, et al.
Publicado: (2016)